Long-Term Pulmonal Therapy of Cystic Fibrosis-Patients with Amitriptyline
Background/Aims: Several recent clinical studies revealed an accumulation of ceramide in bronchial epithelial cells of patients with cystic fibrosis (CF). Degradation of ceramide concentrations in lungs of CF patients employing the functional acid sphingomyelinase inhibitor amitriptyline revealed a...
Main Authors: | Constantin Adams, Vanya Icheva, Caroline Deppisch, Josefine Lauer, Gloria Herrmann, Ute Graepler-Mainka, Susanne Heyder, Erich Gulbins, Joachim Riethmueller |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2016-07-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/445648 |
Similar Items
-
Therapy of CF-Patients with Amitriptyline and Placebo - a Randomised, Double-Blind, Placebo-Controlled Phase IIb Multicenter, Cohort-Study
by: Lutz Nährlich, et al.
Published: (2013-04-01) -
Inhibition of acid sphingomyelinase by tricyclic antidepressants and analogons
by: Nadine eBeckmann, et al.
Published: (2014-09-01) -
Amitriptyline Cardiac Toxicity Treated with Hemoperfusion
by: Nurdan Ünlü, et al.
Published: (2017-04-01) -
Regulation of the Inflammasome by Ceramide in Cystic Fibrosis Lungs
by: Heike Grassmé, et al.
Published: (2014-06-01) -
Prophylactic Treatment for Migraine in Children: Amitriptyline or Topiramate?
by: Gonca Bektaş
Published: (2017-06-01)